Pharmacokinetics, safety and inducible cytokine responses during a phase 1 trial of the oral histone deacetylase inhibitor ITF2357 (givinostat). - Furlan A; Monzani V; Reznikov LL; Leoni F; Fossati G; Modena D; Mascagni P; Dinarello CA (Molecular medicine (Cambridge, Mass.), 2011)